Apol­lomics plans to lay off staff, nar­row fo­cus for lung can­cer tri­al

Apol­lomics is mak­ing ma­jor cost cuts and lead­er­ship changes to stay afloat.

The on­col­o­gy biotech an­nounced Wednes­day morn­ing that co-founder and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.